Effect of bupropion-SR on REM sleep: Relationship to antidepressant response

Psychopharmacology

Volumn 165, Issue 1, 2002, Pages 29-36

  Ott, Geoffrey E ^a   Rao, Uma ^a,b,c   Nuccio, Innocencia ^a   Lin, Keh Ming ^a,b   Poland, Russell E ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Antidepressant; Bupropion SR; Depression; Sleep; Treatment; Wellbutrin SR

Indexed keywords

AMFEBUTAMONE; DOPAMINE 2 RECEPTOR;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG RESPONSE; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; LATENT PERIOD; MAJOR DEPRESSION; MALE; NORADRENERGIC SYSTEM; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REM SLEEP;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PSYCHIATRIC STATUS RATING SCALES; REACTION TIME; SLEEP, REM;

EID: 0036932808     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1165-4     Document Type: Article

References (78)

1. Akiskal HS, Rosenthal TL, Haykal RF, Lemmi H, Rosenthal RH, Scott-Strauss A (1980) Characterological depressions: Clinical and sleep EEG findings separating subaffective dysthymias from character spectrum disorders. Arch Gen Psychiatry 37:777-783
2. 1 receptor stimulation. Eur J Pharmacol 216:157-166
3. Benca RM, Obermeyer WH, Thisted RA, Gillin JC (1992) Sleep and psychiatric disorders: A meta-analysis. Arch Gen Psychiatry 49:651-668
4. Berger M, Riemann D (1993) REM sleep in depression - An overview. J Sleep Res 2:211-223
5. Buchsbaum MS, Wu J, Siegel BV, Hackett E, Trennary M, Abel L, Reynolds C (1997) Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry 41:15-22
6. Buysse DJ, Kupfer DJ, Frank E, Monk TH, Ritenour A, Ehlers CL (1992) Electroencephalographic sleep studies in depressed outpatients treated with interpersonal psychotherapy: I. baseline studies in responders and non-responders. Psychiatry Res 40:13-26
7. Cartwright RD (1993) Sleep problems. In: Costell GG (ed) Symptoms of Depression. Wiley, New York, pp 243-257
8. Charney DS, Berman RM, Miller HL (1998) Treatment of depression. In: Schatzberg AF, Nemeroff CB (eds) The American Psychiatric Press Textbook of Psychopharmacology, 2nd Edn. American Psychiatric Press, Washington D.C. pp 705-731
9. Coble PA, Kupfer DJ, Spiker DG, Neil JF, McPartland RJ (1979) EEG sleep in primary depression: A longitudinal placebo study. J Affect Disord 1:131-138
10. Cooper BR, Hester TJ, Maxwell RA (1980) Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): Evidence for selective blockade of dopamine in vivo. J Pharmacol Exp Ther 215:127-134
11. Dunleavy DLF, Oswald I (1973) Phenelzine: Mood response and sleep. Arch Gen Psychiatry 28:353-356
12. Ehlers CL, Kupfer DJ (1987) Hypothalamic peptide modulation of EEG sleep in depression: A further application of the S-process hypothesis. Biol Psychiatry 22:513-517
13. Ferris RM, Maxwell RA, Cooper BR, Soroko FE (1982) Neurochemical and neuropharmacological investigations into the mechanisms of action of bupropion HCl - A new atypical antidepressant agent. In: Costa E, Racagni G (eds) Advances in Biochemical Psychopharmacology: 1. Typical and Atypical Antidepressants: Molecular Mechanisms. Raven Press, New York, pp 277-286
14. Feuillade P, Pringuey D, Belugou JL, Robert P, Darcourt G (1992) Trimipramine: Acute and lasting effects on sleep in healthy and major depressive subjects. J Affect Disord 24:135-146
15. First MB, Spitzer RL, Gibbon M, Williams JB (1994) Structured Clinical Interview for DSM-IV Axis I Disorders: SCID-I Clinician Version. American Psychiatric Association, Washington D.C.
16. Gaillard J-M, Nicholson AN, Pascoe PA (1994) Neurotransmitter systems. In: Kryger M, Roth T, Dement W (eds) Principles and Practices of Sleep Medicine, 2nd Edn. Saunders, Philadelphia, pp 338-348
17. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M (1997) Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry 2:311-313
18. Gillin JC, Wyatt RJ, Fram D, Snyder F (1978) The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline. Psychopharmacology 59:267-272
19. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 25:56-62
20. Heiligenstein JH, Faries DE, Rush AJ, Andersen JS, Pande AC, Roffwarg HP, Dunner D, Gillin JC, James SP, Lahmeyer H, Zajecka J, Tollefson GD, and Gardner, DM (1994) Latency to rapid eye movement sleep as a predictor of treatment response to fluoxetine and placebo in nonpsychotic depressed outpatients. Psychiatry Res 52:327-339
21. Hochli D, Riemann D, Zulley J, Berger M (1986) Initial REM sleep suppression by clomipramine: A prognostic tool for treatment response in patients with a major depressive disorder. Biol Psychiatry 21:1217-1220
22. Kupfer DJ (1976) REM latency: A psychobiologic marker for primary depressive disease. Biol Psychiatry 11:159-174
23. Kupfer DJ, Foster G, Reich L, Thompson KS, Weiss B (1976) EEG sleep changes as predictors in depression. Am J Psychiatry 133:622-626
24. Kupfer DJ, Spiker DG, Coble PA, Neil JF, Ulrich R, Shaw DH (1981) Sleep and treatment prediction in endogenous depression. Am J Psychiatry 138:429-434
25. Kupfer DJ, Spiker DG, Rossi A, Coble PA, Shaw D, Ulrich R (1982) Nortriptyline and EEG sleep in depressed patients. Biol Psychiatry 17:535-546
26. Landolt H-P, Raimo EB, Schnierow BJ, Kelsoe JR, Rapaport MH, Gillin JC (2001) Sleep and sleep electroencephalogram in depressed patients treated with phenelzine. Arch Gen Psychiatry 58:268-276
27. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL, Silva JA, McGinnis S, Glass TG, Martin CC, Fox PT (1997) Cingulate function in depression: A potential predictor of treatment response. Neuroreport 8:1057-1061
28. McCarley RW, Greene RW, Rainnie D, Portas CM (1995) Brainstem neuromodulation and REM sleep. Semin Neurosci 7:341-354
29. Mendlewicz J, Kempenaers C, de Maertelaer V (1991) Sleep EEG and amitriptyline treatment in depressed inpatients. Biol Psychiatry 30:691-702
30. Monti JM, Hawkins M, Jantos H, D'Angelo L, Fernandez M (1988) Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in rat. Psychopharmacology 95:395-400
31. 1 antagonist SCH 23900 administration in rats. Neuropsychopharmacology 3:153-162
32. Monti JM, Ponzoni A, Jantos H, Lagos P, Silveira R, Banchero P (1999) Effects of accumbens m-chlorophenylbiguanide microinjections on sleep and waking in intact and 6-hydroxy-dopamine-treated rats. Eur J Pharmacol 364:89-98
33. Nofzinger EA, Reynolds CF III, Thase ME, Frank E, Jennings JR, Fasiczka AL, Sullivan LR, Kupfer DJ (1995) REM sleep enhancement by bupropion in depressed men. Am J Psychiatry 152:274-276
34. 18F)FDG PET studies. Psychiatry Res 91:59-78
35. 18F)-FDG PET. Psychiatry Res 106:95-111
36. Oswald I, Adam K (1986) Effects of paroxetine on human sleep. Br J Clin Pharmacol 22:97-99
37. Paykel ES (1994) Epidemiology of refractory depression. In: Nolen WA, Zohar I, Roose SP (eds) Refractory Depression: Current Strategies and Future Directions. Wiley, New York, pp 3-18
38. Poland RE, Tondo L, Rubin RT, Trelease RB, Lesser IM (1989) Differential effects of scopolamine on nocturnal cortisol secretion, sleep architecture, and REM latency in normal volunteers: Relation to sleep and cortisol abnormalities in depression. Biol Psychiatry 25:403-412
39. Poland RE, McCracken JT, Lutchmansingh P, Lesser IM, Tondo L, Edwards C, Boone KB, Lin K-M (1997) Differential response of rapid eye movement sleep to cholinergic blockade by scopolamine in currently depressed, remitted, and normal control subjects. Biol Psychiatry 41:929-938
40. Preskorn SH, Othmer SC (1984) Evaluation of bupropion hydrochloride: The first of a new class of atypical antidepressants. Pharmacotherapy 4:20-34
41. Propping P, Nothen MM (1995) Genetic variation of CNS receptors - A new perspective for pharmacogenetics. Pharmacogenetics 5:318-325
42. Quitkin FM, McGrath PJ, Stewart JW, Ocepek-Welikson K, Taylor BP, Nunes E, Deliyannides D, Agosti V, Donovan SJ, Petkova E, Klein DF (1996) Chronological milestones to guide drug change. When should clinicians switch antidepressants? Arch Gen Psychiatry 53:785-792
43. Rechtschaffen A, Kales A (1968) A Manual of Standardized Terminology, Techniques, and Scoring System for Sleep Stages of Human Subjects. NIH Publication 204, Bethesda, Md.
44. Reynolds CF III, Kupfer DJ (1987) Sleep research in affective illness: State of the art circa 1987. Sleep 10:199-215
45. Reynolds CF III, Hoch CC, Buysse DJ, George CJ, Houck PR, Mazumdar S, Miller M, Pollock BG, Rifai H, Frank E, Cornes C, Moryez RK, Kupfer DJ (1991) Sleep in late-life recurrent depression: Changes during early continuation therapy. Neuropsychopharmacology 5:85-96
46. Rush AJ, Beck T, Kovacs M, Hollen SD (1977) Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed outpatients. Cognit Ther Res 1:17-37
47. Rush AJ, Erman MK, Schlesser MA, Roffwarg HP, Vasavada N, Khatami M, Fairchild C, Giles DE (1985) Alprazolam vs amitriptyline in depressions with reduced REM latencies. Arch Gen Psychiatry 42:1154-1159
48. Rush AJ, Giles DE, Jarrett RB, Feldman-Koffler F, Debus JR, Weissenburger J, Orsulak PJ, Roffwarg HP (1989) Reduced REM latency predicts response to tricyclic medication in depressed outpatients. Biol Psychiatry 26:61-72
49. Rush AJ, Armitage R, Gillin JC, Yonkers KA, Winokur A, Moldofsky H, Vogel GW, Kaplita SB, Fleming JB, Montplaisir J, Erman MK, Albala BJ, McQuade RD (1998) Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorders. Biol Psychiatry 44:3-14
50. Saletu B, Frey R, Krupka M, Anderer P, Grunberger J, See WR (1991) Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities. Sleep 14:439-447
51. Salin-Pascual RJ, Garcia-Polo L, Drucker-Colin R (1997) Sleep changes after four continuous days administration of venlafaxine in normal volunteers. Sleep Res 26:126
52. Sampson D, Willner P, Muscat R (1991) Reversal of antidepressant action by dopamine antagonists in an animal model of depression. Psychopharmacology 104:491-495
53. Settle EC (1998) Bupropion sustained release: Side effect profile. J Clin Psychiatry 59:32-36
54. Sharpley AL, Walsh AES, Cowen PJ (1992) Nefazodone - A novel antidepressant - May increase REM sleep. Biol Psychiatry 31:1070-1073
55. Sharpley AL, Williamson DJ, Attenburrow MEJ, Pearson G, Sargent P, Cowen PJ (1996) The effects of paroxetine and nefazodone on sleep: A placebo controlled trial. Psychopharmacology 126:50-54
56. Soroko FE, Mehta NB, Maxwell RA, Ferris RM, Schroeder DH (1977) Bupropion hydrochloride (±) α-t-butylamino-3-chloro-propiophenone HCl: A novel antidepressant agent. J Pharm Pharmacol 29:767-770
57. Staedt J, Hunerjager H, Ruther E, Stoppe G (1998) Sleep cluster arousal analysis and treatment response to heterocyclic antidepressants in patients with major depression. J Affect Disord 49:221-227
58. Staner L, Kerkhofs M, Detroux D, Leyman S, Linkowski P, Medlewicz J (1995) Acute, subchronic, and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: A double-blind randomized trial in major depression. Sleep 18:470-477
59. Steiger A, Holsboer (1997) Neuropeptides and human sleep. Sleep 20:1038-1052
60. Svendson K, Christensen PG (1981) Duration of REM sleep latency as predictor of effect of antidepressant therapy. Acta Psychiatr Scand 64:238-243
61. Thase ME (1998) Depression, sleep and antidepressants. J Clin Psychiatry 59:55-65
62. Thase ME, Rush AJ (1995) Treatment-resistant depression. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York, pp 1081-1097
63. Thase ME, Simons AD, Reynolds CF III (1996) Abnormal electroencephalographic sleep profiles in major depression: Association with response to cognitive behavior therapy. Arch Gen Psychiatry 53:99-108
64. Thase ME, Buysse DJ, Frank E, Cherry CR, Cornes CL, Mallinger AG, Kupfer DJ (1997) Which depressed patients will respond to interpersonal psychotherapy? The role of abnormal EEG sleep profiles. Am J Psychiatry 154:502-509
65. van Bemmel AL, Havermans AG, van Diest R (1992) Effects of trazodone on EEG sleep and clinical state in major depression. Psychopharmacology 107:569-574
66. van Bemmel AL, van den Hoofdakker RH, Beersma DGM, Bouhuys AL (1993) Changes in sleep polygraphic variables and clinical state in depressed patients during treatment with citalopram. Psychopharmacology 113:225-230
67. van Wyck Fleet J, Manberg PJ, Miller LL, Harto-Truax N, Sato T, Fleck RJ, Stern WC, Cato AE (1983) Overview of clinically significant adverse reactions to bupropion. J Clin Psychiatry 44:191-196
68. Vogel GW, Buffenstein A, Minter K, Hennessey A (1990) Drug effects on REM sleep and on endogenous depression. Neurosci Biobehav Rev 14:49-63
69. Vogel G, Cohen J, Mullis D, Kensler T, Kaplita S (1998) Nefazodone and REM sleep: How do antidepressant drugs decrease REM sleep? Sleep 21:70-77
70. Ware JC, Rose FV, McBrayer RH (1994) The acute effects of nefazodone, trazodone and buspirone on sleep and sleep-related penile tumescence in normal subjects. Sleep 17:544-550
71. Willner P (1995) Dopaminergic mechanisms in depression and mania. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York, pp 921-931
72. Winokur A, Sateia MJ, Hayes JB, Bayles-Dazet W, MacDonald MM, Gary KA (2000) Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: A pilot study. Biol Psychiatry 48:75-78
73. Wilson SJ, Bell C, Coupland NJ, Nutt DJ (2000) Sleep changes during long-term treatment of depression with fluoxamine - A home based study. Psychopharmacology 149:360-365
74. Wisor JP, Seiji N, Sora I, Uhl GH, Mignot E, Edgar DM (2001) Dopaminergic role in stimulant-induced wakefulness. J Neurosci 21:1987-1794
75. Wu J, Buchsbaum MS, Gillin JC, Tang C, Cadwell S, Wiegand M, Najafi A, Klein E, Hazen K, Bunney WE (1999) Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry 156:1149-1158
76. Wu JC, Buchsbaum M, Bunney WE (2001) Clinical neurochemical implications of sleep deprivation's effects on the anterior cingulate of depressed responders. Neuropsychopharmacology 25:S74-S78
77. Wyatt RJ, Kupfer DJ, Scott J, Robinson DS, Snyder F (1969) Longitudinal studies of the effect of monoamine oxidase inhibitors on sleep in man. Psychopharmacologia 15:236-244
78. Zammit Z, Rosenbaum A, Stokes P, Davis J, Zorick F, Roth T (1988) Biological differences in endogenous depressive placebo responders versus non-responders: Dexamethasone suppression test and sleep EEG data. Biol Psychiatry 24:97-101